ondansetron has been researched along with Action Tremor in 5 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We previously demonstrated that nicotine elicited kinetic tremor by elevating the neural activity of the inferior olive via α7 nicotinic acetylcholine (nACh) receptors." | 7.85 | Serotonergic modulation of nicotine-induced kinetic tremor in mice. ( Iha, HA; Kunisawa, N; Matsubara, N; Nomura, Y; Ohno, Y; Onishi, M; Shimizu, S, 2017) |
| "Cerebellar tremor is a frequent and disabling symptom in multiple sclerosis (MS) patients." | 6.70 | Failure of ondansetron in treating cerebellar tremor in MS patients--an open-label pilot study. ( Buhmann, C; Gbadamosi, J; Heesen, C; Moench, A, 2001) |
| "We previously demonstrated that nicotine elicited kinetic tremor by elevating the neural activity of the inferior olive via α7 nicotinic acetylcholine (nACh) receptors." | 3.85 | Serotonergic modulation of nicotine-induced kinetic tremor in mice. ( Iha, HA; Kunisawa, N; Matsubara, N; Nomura, Y; Ohno, Y; Onishi, M; Shimizu, S, 2017) |
| "Cerebellar tremor is a frequent and disabling symptom in multiple sclerosis (MS) patients." | 2.70 | Failure of ondansetron in treating cerebellar tremor in MS patients--an open-label pilot study. ( Buhmann, C; Gbadamosi, J; Heesen, C; Moench, A, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kunisawa, N | 1 |
| Iha, HA | 1 |
| Nomura, Y | 1 |
| Onishi, M | 1 |
| Matsubara, N | 1 |
| Shimizu, S | 1 |
| Ohno, Y | 1 |
| Vadivelu, S | 1 |
| Tomlinson, K | 1 |
| Valles, J | 1 |
| Hundert, M | 1 |
| Bagdonas, R | 1 |
| Eisenberg, M | 1 |
| Rice, GP | 1 |
| Lesaux, J | 1 |
| Vandervoort, P | 1 |
| Macewan, L | 1 |
| Ebers, GC | 1 |
| Gbadamosi, J | 1 |
| Buhmann, C | 1 |
| Moench, A | 1 |
| Heesen, C | 1 |
| Jacobsen, MB | 1 |
2 trials available for ondansetron and Action Tremor
| Article | Year |
|---|---|
Ondansetron, a 5-HT3 antagonist, improves cerebellar tremor.
Topics: Cerebellar Diseases; Cross-Over Studies; Double-Blind Method; Humans; Injections, Intravenous; Ondan | 1997 |
Failure of ondansetron in treating cerebellar tremor in MS patients--an open-label pilot study.
Topics: Adult; Cerebellar Diseases; Female; Humans; Injections, Intravenous; Male; Multiple Sclerosis; Ondan | 2001 |
3 other studies available for ondansetron and Action Tremor
| Article | Year |
|---|---|
Serotonergic modulation of nicotine-induced kinetic tremor in mice.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Fenclonine; Humans; Male; Mice; Nicot | 2017 |
Acute anti-emetic withdrawal associated with a hemorrhagic cerebellar arteriovenous malformation.
Topics: Aged; Antiemetics; Arteriovenous Fistula; Cerebellum; Flushing; Humans; Intracranial Arteriovenous M | 2010 |
Ondansetron in carcinoid syndrome.
Topics: Aged; Carcinoid Tumor; Humans; Imidazoles; Male; Ondansetron; Pancreatic Neoplasms; Serotonin Antago | 1992 |